Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
about
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study
P2860
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prognostic factors in 868 adva ...... hemotherapy in the real world.
@en
Prognostic factors in 868 adva ...... hemotherapy in the real world.
@nl
type
label
Prognostic factors in 868 adva ...... hemotherapy in the real world.
@en
Prognostic factors in 868 adva ...... hemotherapy in the real world.
@nl
prefLabel
Prognostic factors in 868 adva ...... hemotherapy in the real world.
@en
Prognostic factors in 868 adva ...... hemotherapy in the real world.
@nl
P2093
P2860
P50
P1433
P1476
Prognostic factors in 868 adva ...... chemotherapy in the real world
@en
P2093
Antonio Pellegrino
Caterina Fontanella
Daniele Santini
Eufemia Stefania Lutrino
Gerardo Rosati
Gianluca Tomasello
Giulia Pasquini
Giuseppe Aprile
Lorenzo Antonuzzo
Mario Scartozzi
P2860
P2888
P304
P356
10.1007/S10120-016-0681-6
P50
P577
2016-12-27T00:00:00Z